Live feed
Filing
SC 13D/A
SC 13D/A0001213900-24-099322·Pontifax Management III G.P. (2011) Ltd.
Schedule 13D ownership disclosure
UROGEN PHARMA LTD
Security class unavailable · CUSIP: M96088105
Event date: 2024-03-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1
- Percent of class
- 4.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-099322
- Form type
- SC 13D/A
- Filer
- Pontifax Management III G.P. (2011) Ltd.
- CIK
- CIK 1726335
- Filed
- Nov 18, 2024
- Reporting period
- Mar 14, 2024
- Description
- Schedule 13D beneficial ownership